Topic Hub
25 clinically reviewed articles, written and peer-reviewed by the HealthRX.com Medical Team.
Explore
Showing 25 of 25 clinical reviews.
A physician-level guide to oral micronized progesterone (Prometrium) pharmacokinetics, absorption variability, and dosing strategy after Roux-en-Y gastric bypass, sleeve gastrectomy, and other bariatric procedures. Covers the PEPI Trial evidence base, post-bariatric malabsorption data, and when to switch routes.
Read clinical reviewA physician-level review of how oral micronized progesterone (Prometrium) interacts with autoimmune conditions, including lupus, MS, rheumatoid arthritis, and thyroid disease, with primary-literature citations throughout.
Read clinical reviewA clinician-level review of how oral micronized progesterone (Prometrium) affects cognitive function, memory, mood, and neuroprotection, with primary-literature citations and dosing guidance.
Read clinical reviewA physician-reviewed, evidence-based analysis of how oral micronized progesterone (Prometrium) affects liver function, hepatic metabolism, and transaminase levels, with citations to PEPI, FDA labeling, and primary pharmacokinetic literature.
Read clinical reviewA physician-reviewed deep dive into how oral micronized progesterone (Prometrium) affects skeletal muscle, with evidence-based strategies to preserve lean mass during hormone therapy.
Read clinical reviewA clinician-level review of how oral micronized progesterone (Prometrium) affects libido, arousal, vaginal health, and mood-related sexual outcomes in women on HRT, with primary-literature citations and practical dosing guidance.
Read clinical reviewA clinician-level review of how oral micronized progesterone (Prometrium) affects bone mineral density, the mechanisms behind it, key trial data, and practical prescribing guidance for HRT patients.
Read clinical reviewA physician-level review of cancer risk signals associated with oral micronized progesterone (Prometrium), covering breast, endometrial, ovarian, and colorectal data from major trials and observational cohorts.
Read clinical reviewA clinician-level review of oral micronized progesterone (Prometrium) cardiovascular effects, covering lipid profiles, arterial function, coronary risk, and how it compares to synthetic progestins in long-term hormone therapy.
Read clinical reviewA clinical review of oral micronized progesterone (Prometrium) microdosing protocols, covering dose ranges, endometrial protection data, sleep and mood effects, and how evidence-based sub-standard dosing fits into modern HRT practice.
Read clinical reviewMD/PharmD-level guide to diagnosing and correcting oral micronized progesterone (Prometrium) plateau and non-response: absorption issues, dosing gaps, hormone interactions, and clinical decision trees.
Read clinical reviewWhen to stop oral micronized progesterone (Prometrium) before surgery, why the hold matters, and how to restart safely. MD-level guidance with primary-source citations.
Read clinical reviewWhat happens when you stop oral micronized progesterone (Prometrium)? A physician-reviewed guide to rebound symptoms, withdrawal timelines, tapering strategies, and the latest clinical evidence.
Read clinical reviewA physician-level guide to oral micronized progesterone (Prometrium) seasonal use considerations, including dose timing, light-exposure effects on metabolism, sleep changes across seasons, and practical clinical protocols.
Read clinical reviewA clinician-level review of how oral micronized progesterone (Prometrium) reshapes sleep architecture, with primary-literature citations, dosing guidance, and practical prescribing considerations for HRT patients.
Read clinical reviewA physician-level guide to adjusting oral micronized progesterone (Prometrium) dosing during travel, transmeridian flights, and timezone shifts, with primary-literature citations and a clinical decision framework.
Read clinical reviewDoes oral micronized progesterone (Prometrium) increase appetite or trigger cravings? A clinician-level review of the evidence, mechanisms, and management strategies for women on HRT.
Read clinical reviewA clinician-level comparison of compounded oral micronized progesterone versus brand-name Prometrium, covering bioavailability, safety data, FDA regulation, cost, and how to choose between them for HRT.
Read clinical reviewA GRADE-graded review of oral micronized progesterone (Prometrium) for endometrial protection on HRT, covering the PEPI trial, sleep and mood data, cardiovascular signals, and current guideline recommendations.
Read clinical reviewA clinician-reviewed guide to how oral micronized progesterone (Prometrium) affects hair growth, hair loss, sebum, and skin quality, with primary-literature citations and dosing context.
Read clinical reviewA clinician-reviewed guide to how oral micronized progesterone (Prometrium) affects mood, anxiety, sleep, and depression, with primary-literature citations, dosing context, and practical guidance for patients on hormone therapy.
Read clinical reviewA clinician-level review of how oral micronized progesterone (Prometrium) affects metabolic rate, thermogenesis, insulin sensitivity, and body composition, with primary-literature citations throughout.
Read clinical reviewA physician-level review of oral micronized progesterone (Prometrium) and kidney outcomes, covering aldosterone antagonism, blood pressure effects, CKD dosing considerations, and the latest clinical evidence.
Read clinical reviewA clinician-level guide to safely restarting oral micronized progesterone (Prometrium) after an acute illness, covering pharmacology, timing, dose adjustment, and monitoring protocols backed by primary literature.
Read clinical reviewA week-by-week guide to oral micronized progesterone (Prometrium) in the first month of HRT, covering sleep, spotting, mood shifts, and side-effect timelines, grounded in PEPI Trial data and current prescribing guidelines.
Read clinical review